Battle royale

Systemic versus locoregional therapy for unresectable hepatocellular carcinoma

Research output: Contribution to journalReview article

Abstract

OBJECTIVE. This commentary discusses research examining comparisons of locoregional therapy with systemic therapy for unresectable hepatocellular carcinoma (HCC). CONCLUSION. Comparison of patient outcomes after locoregional or systemic therapy for HCC is confounded by selection bias, wherein patients chosen for locoregional therapy usually have better underlying liver function that may contribute to the observed longer survival.

Original languageEnglish (US)
Pages (from-to)1366-1367
Number of pages2
JournalAmerican Journal of Roentgenology
Volume210
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Hepatocellular Carcinoma
Selection Bias
Therapeutics
Survival
Liver
Research

Keywords

  • Chemoembolization, hepatocellular carcinoma

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Battle royale : Systemic versus locoregional therapy for unresectable hepatocellular carcinoma. / Naugler, Willscott (Scott).

In: American Journal of Roentgenology, Vol. 210, No. 6, 01.06.2018, p. 1366-1367.

Research output: Contribution to journalReview article

@article{dc147e82fa44470e8df6cd59de77fe2a,
title = "Battle royale: Systemic versus locoregional therapy for unresectable hepatocellular carcinoma",
abstract = "OBJECTIVE. This commentary discusses research examining comparisons of locoregional therapy with systemic therapy for unresectable hepatocellular carcinoma (HCC). CONCLUSION. Comparison of patient outcomes after locoregional or systemic therapy for HCC is confounded by selection bias, wherein patients chosen for locoregional therapy usually have better underlying liver function that may contribute to the observed longer survival.",
keywords = "Chemoembolization, hepatocellular carcinoma",
author = "Naugler, {Willscott (Scott)}",
year = "2018",
month = "6",
day = "1",
doi = "10.2214/AJR.17.19392",
language = "English (US)",
volume = "210",
pages = "1366--1367",
journal = "AJR. American journal of roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "6",

}

TY - JOUR

T1 - Battle royale

T2 - Systemic versus locoregional therapy for unresectable hepatocellular carcinoma

AU - Naugler, Willscott (Scott)

PY - 2018/6/1

Y1 - 2018/6/1

N2 - OBJECTIVE. This commentary discusses research examining comparisons of locoregional therapy with systemic therapy for unresectable hepatocellular carcinoma (HCC). CONCLUSION. Comparison of patient outcomes after locoregional or systemic therapy for HCC is confounded by selection bias, wherein patients chosen for locoregional therapy usually have better underlying liver function that may contribute to the observed longer survival.

AB - OBJECTIVE. This commentary discusses research examining comparisons of locoregional therapy with systemic therapy for unresectable hepatocellular carcinoma (HCC). CONCLUSION. Comparison of patient outcomes after locoregional or systemic therapy for HCC is confounded by selection bias, wherein patients chosen for locoregional therapy usually have better underlying liver function that may contribute to the observed longer survival.

KW - Chemoembolization, hepatocellular carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85047749274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047749274&partnerID=8YFLogxK

U2 - 10.2214/AJR.17.19392

DO - 10.2214/AJR.17.19392

M3 - Review article

VL - 210

SP - 1366

EP - 1367

JO - AJR. American journal of roentgenology

JF - AJR. American journal of roentgenology

SN - 0361-803X

IS - 6

ER -